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Background: Cardiomyopathy is an independent predictor of morbidity and early mortality in mitochondrial DNA disease, and occurs in 20-40% 
adult patients harboring the common m.3243A>G mutation, usually with a hypertrophic phenotype. Pathogenetic mechanisms are unclear yet no 
prospective study of myocardial structure and function has been performed to identify antecedent markers of cardiac involvement.
Methods: Cardiac magnetic resonance imaging and tagging analysis was performed in 20 adult patients with mitochondrial disease harboring the 
m.3243A>G mutation, without clinical cardiovascular disease, and 20 age- and gender-matched healthy controls.
Results: Compared to controls, patients had increased left ventricular mass index (LVMI), LV mass to end-diastolic volume ratio (M/V ratio), radial 
wall thicknesses and peak torsion (Table); longitudinal shortening was decreased but there were no significant differences in diastolic function. 
Among patients there was no significant correlation of LVMI or M/V ratio with blood pressures or diabetic status but urinary mutation load was 
associated with LVMI (r=0.78, p<0.01).
Conclusions: Concentric cardiac remodeling is identifiable in patients harboring the m.3243A>G mutation without clinical cardiovascular disease. 
This occurs in association with characteristic changes in systolic intramyocardial strains and torsion, and patients with higher mutation loads may be 
at increased risk of developing cardiomyopathy.
Table
Parameter Carriers(n=20)
Controls
(n=20) p value
Baseline characteristics
Age (years) 38.7 ± 13.1 38.4 ± 14.2 ns
Male gender, n (%) 10 (50) 10 (50) ns
Height (cm) 172 ± 10 174 ± 11 ns
Weight (kg) 63.5 ± 14.2 76.1 ± 11.1 0.02
Body surface area (m2) 1.74 ± 0.18 1.81 ± 0.22 ns
Diabetes mellitus, n (%) 8 (40) 0 (0) N/A
Hypertension, n (%) 2 (10) 0 (0) N/A
Heart rate (min-1) 78 ± 13 60 ± 8 <0.0001
SBP (mmHg) 115 ± 14 120 ± 12 ns
DBP (mmHg) 77 ± 8 74 ± 9 ns
Cardiac morphology and function
End-diastolic volume (ml) 101 ± 20 139 ± 25 <0.0001
End-systolic volume (ml) 40 ± 10 58 ± 16 <0.001
Stroke volume (ml) 60 ± 12 81 ± 14 <0.0001
Cardiac output (l/min) 4.8 ± 1.1 4.8 ± 0.8 ns
Ejection fraction (%) 61 ± 8 60 ± 6 ns
LV mass (g) 119 ± 26 110 ± 22 ns
Wall thickness in systole (mm) 13.3 ± 2.6 10.8 ± 2.1 <0.01
Wall thickness in diastole (mm) 9.8 ± 2.9 6.8 ± 1.1 <0.001
LVMI [LV mass/BSA] (g/m2) 71 ± 11 59 ± 9 <0.01
M/V ratio [LV mass/end-diastolic volume] (g/ml) 1.21 ± 0.31 0.79 ± 0.12 <0.0001
E/A ratio 1.63 ± 0.48 1.81 ± 0.53 ns
Early filling percentage (%) 72.4 ± 5.7 71.2 ± 6.6 ns
Myocardial strains
Longitudinal shortening (%) 15.0 ± 1.9 18.8 ± 2.0 <0.0001
Radial wall thickening (%) 66.4 ± 13.5 63.3 ± 17.1 ns
Peak torsion (°) 8.4 ± 3.1 5.3 ± 1.5 <0.01
Systolic torsion rate (°/s) 36 ± 12 27 ± 11 0.03
Diastolic torsion rate (°/s) -20 ± 7 -18 ± 11 ns
Peak circumferential whole wall strain (%) 18.0 ± 2.8 18.2 ± 2.3 ns
Peak circumferential endocardial strain (%) 24.3 ± 3.2 24.1 ± 2.6 ns
Torsion to endocardial strain ratio (rad) 0.68 ± 0.18 0.54 ± 0.10 ns
